Magnetar Financial LLC raised its position in Cigna Group (NYSE:CI – Free Report) by 789.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,478 shares of the health services provider’s stock after acquiring an additional 17,287 shares during the quarter. Magnetar Financial LLC’s holdings in Cigna Group were worth $5,615,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the company. Norges Bank purchased a new stake in shares of Cigna Group during the 2nd quarter valued at about $1,110,426,000. Capital Research Global Investors boosted its holdings in shares of Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after buying an additional 1,855,897 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in Cigna Group by 24.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after buying an additional 492,045 shares during the period. Balyasny Asset Management L.P. grew its position in Cigna Group by 1,057.2% during the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock valued at $133,803,000 after buying an additional 369,775 shares during the period. Finally, Man Group plc increased its holdings in Cigna Group by 215.5% during the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after buying an additional 363,510 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Piper Sandler reduced their price objective on Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. TD Cowen raised their target price on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, February 9th. Barclays lowered their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday, February 6th. Finally, Royal Bank Of Canada reduced their price target on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $330.42.
Cigna Group Stock Performance
CI opened at $260.79 on Thursday. The company has a 50 day simple moving average of $280.01 and a two-hundred day simple moving average of $283.29. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The firm has a market cap of $68.73 billion, a P/E ratio of 11.76, a PEG ratio of 0.91 and a beta of 0.27. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same period last year, the firm earned $6.64 EPS. The company’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a dividend yield of 2.4%. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.
Insider Activity
In other news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by insiders.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
- Five stocks we like better than Cigna Group
- “This AI Giant is About to Go Bust”
- Is Trump Done? Shocking leak…
- I tried out Elon Musk’s new AI tech — it floored me
- “I just bought 10,000 shares of a $5 stock…”
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
